RVT-101 for Dementia with Lewy Bodies (HEADWAY-DLB)

headway_logo3

Axovant Sciences, have announced their decision to discontinue the HEADWAY-DLB study. The Lewy Body Society is obviously very disappointed at this news and especially for those of our supporters who took part in the trials. The project tested the efficacy …